Streetbeat News

Revenues

HUM

Analysts have varied opinions on Humana (NYSE:HUM), with recent ratings showing a mix of bullish, neutral, and bearish sentiments. The average 12-month price target for Humana has increased by 3.52% to $381.1. Humana's financial performance shows strong revenue growth but challenges in net margin and debt management.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 5:00 pm

ACHC

Acadia Healthcare Co (NASDAQ:ACHC) has been analyzed by 9 analysts, showing a range of sentiments from indifferent to somewhat bullish. The average 12-month price target is $88.0, with a high of $94.00 and a low of $75.00. Analysts have maintained or adjusted their ratings, reflecting their views on the company's market position and financial performance. Acadia Healthcare Co has shown positive revenue growth and strong financial metrics, including a net margin of 9.86% and a debt-to-equity ratio of 0.67.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 5:00 pm

DE

Deere (NYSE:DE) has significantly outperformed the market over the past 5 years, with an annualized return of 20.51%. A $100 investment in Deere 5 years ago would now be worth $240.52, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 5:00 pm

AIT

Applied Industrial Techs (NYSE:AIT) has outperformed the market over the past 20 years with an average annual return of 14.48%, surpassing the market by 6.08% annually. A $100 investment in AIT 20 years ago would now be worth $1,496.21.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 5:00 pm

STLD

Steel Dynamics (NASDAQ:STLD) has significantly outperformed the market over the past 20 years, with an average annual return of 14.63%. A $1000 investment in STLD 20 years ago would now be worth $15,391.48. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 4:30 pm

ORCL

Oracle (NYSE:ORCL) has outperformed the market over the past 15 years with an average annual return of 12.91%. A $100 investment in Oracle 15 years ago would now be worth $615.91. This highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 4:30 pm

SMCI

Super Micro Computer Inc (NASDAQ:SMCI) shares fell by 2.6% after a strong previous week driven by positive U.S. retail sales data and a smaller-than-expected increase in producer prices. The stock's recent surge was also supported by Soros Fund Management's purchase of shares. The cooling inflation may lead to lower interest rates, benefiting companies like SMCI with reduced borrowing costs.

Portfolio Pulse from Henry Khederian

August 19, 2024 | 4:16 pm

GLASF

Glass House Brands Inc. is considering diversifying into the hemp sector, leveraging its existing greenhouses. The company reported a record-setting Q2 2024 with $53.9 million in revenue. CEO Kyle Kazan is exploring direct-to-consumer hemp products and sees potential in both cannabis and hemp markets. The move comes amid challenges in California's cannabis market due to over-taxation and falling prices.

Portfolio Pulse from Jelena Martinovic

August 19, 2024 | 4:11 pm

RGLD

Analysts have mixed ratings for Royal Gold (NASDAQ:RGLD) with recent upgrades in price targets. The average 12-month price target increased by 3.8% to $156.0. Royal Gold shows strong financial performance with high net margins and low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 4:00 pm

ELV

Analysts have provided a range of ratings for Elevance Health (NYSE:ELV) over the past three months, with most being somewhat bullish. The average 12-month price target is $607.47, slightly down from previous estimates. Despite a slight revenue decline, Elevance Health shows strong financial performance with high net margins and ROE. However, it faces challenges in debt management.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 4:00 pm